

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | desmosome organization (GO:0002934) | 5.44533629 |
| 2 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 5.23326831 |
| 3 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 5.07521899 |
| 4 | plasma membrane repair (GO:0001778) | 4.88435177 |
| 5 | sarcomere organization (GO:0045214) | 4.87632672 |
| 6 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 4.73824669 |
| 7 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 4.64060770 |
| 8 | cardiac myofibril assembly (GO:0055003) | 4.58541936 |
| 9 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 4.55123058 |
| 10 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 4.40599798 |
| 11 | cell communication involved in cardiac conduction (GO:0086065) | 4.31264566 |
| 12 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 4.29616691 |
| 13 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 4.29551083 |
| 14 | ventricular cardiac muscle cell action potential (GO:0086005) | 4.27479430 |
| 15 | hemidesmosome assembly (GO:0031581) | 4.26106027 |
| 16 | cardiac muscle contraction (GO:0060048) | 4.25724190 |
| 17 | myofibril assembly (GO:0030239) | 4.19733318 |
| 18 | actin-myosin filament sliding (GO:0033275) | 4.13967821 |
| 19 | muscle filament sliding (GO:0030049) | 4.13967821 |
| 20 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 4.13530828 |
| 21 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 4.07473168 |
| 22 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.93301692 |
| 23 | regulation of skeletal muscle contraction (GO:0014819) | 3.91645050 |
| 24 | regulation of membrane repolarization (GO:0060306) | 3.89212447 |
| 25 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.83817061 |
| 26 | regulation of tight junction assembly (GO:2000810) | 3.68164362 |
| 27 | regulation of cell communication by electrical coupling (GO:0010649) | 3.66590503 |
| 28 | detection of calcium ion (GO:0005513) | 3.61591698 |
| 29 | tricarboxylic acid cycle (GO:0006099) | 3.60813211 |
| 30 | striated muscle contraction (GO:0006941) | 3.60198704 |
| 31 | cell communication by electrical coupling (GO:0010644) | 3.54394100 |
| 32 | cardiac conduction (GO:0061337) | 3.53445176 |
| 33 | hypotonic response (GO:0006971) | 3.52282466 |
| 34 | regulation of heart rate by cardiac conduction (GO:0086091) | 3.51143454 |
| 35 | regulation of actin filament-based movement (GO:1903115) | 3.50623342 |
| 36 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 3.44677779 |
| 37 | acrosome reaction (GO:0007340) | 3.44301371 |
| 38 | cardiac muscle cell action potential involved in contraction (GO:0086002) | 3.43158748 |
| 39 | actin-mediated cell contraction (GO:0070252) | 3.42629808 |
| 40 | cardiac muscle cell action potential (GO:0086001) | 3.40471241 |
| 41 | regulation of relaxation of muscle (GO:1901077) | 3.38978313 |
| 42 | cardiac muscle cell development (GO:0055013) | 3.28060720 |
| 43 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 3.26634984 |
| 44 | regulation of calcium ion transmembrane transport (GO:1903169) | 3.26634984 |
| 45 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.26437732 |
| 46 | sperm motility (GO:0030317) | 3.25954719 |
| 47 | macroautophagy (GO:0016236) | 3.22918945 |
| 48 | membrane depolarization during action potential (GO:0086010) | 3.19659969 |
| 49 | actomyosin structure organization (GO:0031032) | 3.19206412 |
| 50 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 3.18069818 |
| 51 | regulation of synapse structural plasticity (GO:0051823) | 3.13885899 |
| 52 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 3.13285481 |
| 53 | membrane raft organization (GO:0031579) | 3.11823194 |
| 54 | regulation of striated muscle contraction (GO:0006942) | 3.11566966 |
| 55 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.10587982 |
| 56 | toxin transport (GO:1901998) | 3.09764912 |
| 57 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 3.09258578 |
| 58 | cardiac muscle hypertrophy (GO:0003300) | 3.07440568 |
| 59 | cardiac cell development (GO:0055006) | 3.07347139 |
| 60 | regulation of type B pancreatic cell apoptotic process (GO:2000674) | 3.03272973 |
| 61 | adult heart development (GO:0007512) | 3.01601528 |
| 62 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 3.01196021 |
| 63 | striated muscle hypertrophy (GO:0014897) | 2.99488955 |
| 64 | barbed-end actin filament capping (GO:0051016) | 2.98176831 |
| 65 | regulation of heart rate (GO:0002027) | 2.98137737 |
| 66 | carnitine shuttle (GO:0006853) | 2.97325209 |
| 67 | negative regulation of inclusion body assembly (GO:0090084) | 2.96609799 |
| 68 | cardiac muscle tissue morphogenesis (GO:0055008) | 2.94971179 |
| 69 | epithelial cilium movement (GO:0003351) | 2.94486449 |
| 70 | regulation of the force of heart contraction (GO:0002026) | 2.92364383 |
| 71 | cell adhesion mediated by integrin (GO:0033627) | 2.91854275 |
| 72 | negative regulation of potassium ion transport (GO:0043267) | 2.87895225 |
| 73 | regulation of necroptotic process (GO:0060544) | 2.87678276 |
| 74 | relaxation of cardiac muscle (GO:0055119) | 2.87445604 |
| 75 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 2.87144671 |
| 76 | regulation of sarcomere organization (GO:0060297) | 2.83760315 |
| 77 | ventricular cardiac muscle tissue morphogenesis (GO:0055010) | 2.82028266 |
| 78 | regulation of potassium ion transmembrane transport (GO:1901379) | 2.81991797 |
| 79 | regulation of cofactor metabolic process (GO:0051193) | 2.80910044 |
| 80 | regulation of coenzyme metabolic process (GO:0051196) | 2.80910044 |
| 81 | heart trabecula formation (GO:0060347) | 2.80620728 |
| 82 | fusion of sperm to egg plasma membrane (GO:0007342) | 2.79982932 |
| 83 | axonemal dynein complex assembly (GO:0070286) | 2.79734582 |
| 84 | potassium ion import (GO:0010107) | 2.78784889 |
| 85 | positive regulation of cation channel activity (GO:2001259) | 2.78412569 |
| 86 | cilium movement (GO:0003341) | 2.78243830 |
| 87 | carnitine transmembrane transport (GO:1902603) | 2.77812704 |
| 88 | negative regulation of necroptotic process (GO:0060546) | 2.77459453 |
| 89 | regulation of potassium ion transmembrane transporter activity (GO:1901016) | 2.76473082 |
| 90 | negative regulation of sodium ion transport (GO:0010766) | 2.75521464 |
| 91 | positive regulation of potassium ion transport (GO:0043268) | 2.75417736 |
| 92 | vocalization behavior (GO:0071625) | 2.75196431 |
| 93 | regulation of heart contraction (GO:0008016) | 2.74471158 |
| 94 | negative regulation of ion transmembrane transporter activity (GO:0032413) | 2.74413116 |
| 95 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 2.73492001 |
| 96 | regulation of cation channel activity (GO:2001257) | 2.73283854 |
| 97 | regulation of cardiac muscle contraction (GO:0055117) | 2.71994399 |
| 98 | neuronal action potential propagation (GO:0019227) | 2.71987037 |
| 99 | muscle tissue morphogenesis (GO:0060415) | 2.70860861 |
| 100 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 2.70759877 |
| 101 | growth hormone receptor signaling pathway (GO:0060396) | 2.70194525 |
| 102 | calcium ion-dependent exocytosis (GO:0017156) | 2.69719926 |
| 103 | membrane repolarization (GO:0086009) | 2.69441576 |
| 104 | multicellular organismal signaling (GO:0035637) | 2.68715891 |
| 105 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.66934712 |
| 106 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 2.65620998 |
| 107 | neurological system process involved in regulation of systemic arterial blood pressure (GO:0001976) | 2.64610230 |
| 108 | striatum development (GO:0021756) | 2.64219125 |
| 109 | response to inactivity (GO:0014854) | 2.64050294 |
| 110 | motile cilium assembly (GO:0044458) | 2.62970909 |
| 111 | negative regulation of protein localization to cell surface (GO:2000009) | 2.61761391 |
| 112 | calcium-mediated signaling using intracellular calcium source (GO:0035584) | 2.61218249 |
| 113 | carnitine transport (GO:0015879) | 2.60888558 |
| 114 | amino-acid betaine transport (GO:0015838) | 2.60888558 |
| 115 | activation of protein kinase A activity (GO:0034199) | 2.60637014 |
| 116 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.57383962 |
| 117 | establishment of skin barrier (GO:0061436) | 2.55572878 |
| 118 | positive regulation of receptor recycling (GO:0001921) | 2.50975485 |
| 119 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.48596216 |
| 120 | retrograde transport, vesicle recycling within Golgi (GO:0000301) | 2.44707543 |
| 121 | regulation of epidermal growth factor-activated receptor activity (GO:0007176) | 2.44684792 |
| 122 | cell-substrate junction assembly (GO:0007044) | 2.39510711 |
| 123 | signal complex assembly (GO:0007172) | 2.37588021 |
| 124 | keratinocyte development (GO:0003334) | 2.37247150 |
| 125 | skin morphogenesis (GO:0043589) | 2.37003257 |
| 126 | regulation of necrotic cell death (GO:0010939) | 2.34896036 |
| 127 | protein localization to endosome (GO:0036010) | 2.34813830 |
| 128 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.34114051 |
| 129 | smooth muscle tissue development (GO:0048745) | 2.33527463 |
| 130 | regulation of water loss via skin (GO:0033561) | 2.30071966 |
| 131 | cellular response to growth hormone stimulus (GO:0071378) | 2.29758638 |
| 132 | protein targeting to Golgi (GO:0000042) | 2.29215920 |
| 133 | interleukin-6-mediated signaling pathway (GO:0070102) | 2.28068402 |
| 134 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.27987175 |
| 135 | negative regulation of systemic arterial blood pressure (GO:0003085) | 2.27113166 |
| 136 | Golgi to endosome transport (GO:0006895) | 2.25700475 |
| 137 | phospholipid translocation (GO:0045332) | 2.25111179 |
| 138 | lipid translocation (GO:0034204) | 2.25111179 |
| 139 | establishment of protein localization to Golgi (GO:0072600) | 2.18938682 |
| 140 | negative regulation of necrotic cell death (GO:0060547) | 2.17441954 |
| 141 | keratinocyte proliferation (GO:0043616) | 2.15249158 |
| 142 | cellular response to arsenic-containing substance (GO:0071243) | 2.15166034 |
| 143 | estrogen biosynthetic process (GO:0006703) | 2.14007510 |
| 144 | syncytium formation by plasma membrane fusion (GO:0000768) | 2.08466376 |
| 145 | apoptotic cell clearance (GO:0043277) | 2.07434319 |
| 146 | regulation of transforming growth factor beta1 production (GO:0032908) | 2.06339384 |
| 147 | actin filament-based movement (GO:0030048) | 2.05944844 |
| 148 | positive regulation of epidermal growth factor-activated receptor activity (GO:0045741) | 2.05677363 |
| 149 | Golgi to plasma membrane protein transport (GO:0043001) | 2.05269076 |
| 150 | platelet-derived growth factor receptor signaling pathway (GO:0048008) | 2.04701251 |
| 151 | early endosome to late endosome transport (GO:0045022) | 2.03266832 |
| 152 | protein localization to cell surface (GO:0034394) | 2.01546929 |
| 153 | protein hydroxylation (GO:0018126) | 2.00711002 |
| 154 | regulation of receptor recycling (GO:0001919) | 2.00358538 |
| 155 | vesicle transport along microtubule (GO:0047496) | 2.00002774 |
| 156 | endodermal cell differentiation (GO:0035987) | 1.97281272 |
| 157 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 1.95022615 |
| 158 | myoblast fusion (GO:0007520) | 1.94820968 |
| 159 | negative regulation of epidermal growth factor-activated receptor activity (GO:0007175) | 1.92884862 |
| 160 | negative regulation of protein localization to plasma membrane (GO:1903077) | 1.92245116 |
| 161 | peptide cross-linking (GO:0018149) | 1.92077668 |
| 162 | cellular response to vitamin (GO:0071295) | 1.86655763 |
| 163 | oligosaccharide catabolic process (GO:0009313) | 1.86613287 |
| 164 | regulation of ARF protein signal transduction (GO:0032012) | 1.84758019 |
| 165 | plasma membrane fusion (GO:0045026) | 1.84598295 |
| 166 | positive regulation of phosphoprotein phosphatase activity (GO:0032516) | 1.83837412 |
| 167 | regulation of skeletal muscle cell differentiation (GO:2001014) | 1.83226607 |
| 168 | keratinization (GO:0031424) | 1.83152288 |
| 169 | heterotypic cell-cell adhesion (GO:0034113) | 1.82882048 |
| 170 | import into cell (GO:0098657) | 1.82774939 |
| 171 | positive regulation of T cell chemotaxis (GO:0010820) | 1.82114796 |
| 172 | regulation of T cell chemotaxis (GO:0010819) | 1.82114796 |
| 173 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 1.81136549 |
| 174 | skeletal muscle tissue regeneration (GO:0043403) | 1.81066353 |
| 175 | positive regulation of myoblast differentiation (GO:0045663) | 1.81010826 |
| 176 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 1.81004418 |
| 177 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 1.80954187 |
| 178 | negative regulation of establishment of protein localization to plasma membrane (GO:0090005) | 1.79996151 |
| 179 | Golgi to plasma membrane transport (GO:0006893) | 1.79237431 |
| 180 | keratan sulfate catabolic process (GO:0042340) | 1.79102515 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.19371528 |
| 2 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 4.55647282 |
| 3 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.88655699 |
| 4 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.40563363 |
| 5 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.21633314 |
| 6 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.15470032 |
| 7 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.13473917 |
| 8 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.12647680 |
| 9 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 2.06017487 |
| 10 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.96371550 |
| 11 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.95585104 |
| 12 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.95431597 |
| 13 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.95014515 |
| 14 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.94488750 |
| 15 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.93734457 |
| 16 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.93064295 |
| 17 | GATA1_22025678_ChIP-Seq_K562_Human | 1.92689587 |
| 18 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.92482384 |
| 19 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.92482384 |
| 20 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.92165459 |
| 21 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.91595398 |
| 22 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.82925434 |
| 23 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.82454611 |
| 24 | CJUN_26792858_Chip-Seq_BT549_Human | 1.82096946 |
| 25 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.81804548 |
| 26 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.78145147 |
| 27 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.77701088 |
| 28 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.75663090 |
| 29 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.72500040 |
| 30 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.72500040 |
| 31 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.71610106 |
| 32 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.68795079 |
| 33 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.68435235 |
| 34 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.68317425 |
| 35 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.67143610 |
| 36 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.65333606 |
| 37 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.63271711 |
| 38 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.63031777 |
| 39 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.62482480 |
| 40 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.62482480 |
| 41 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.62050568 |
| 42 | VDR_22108803_ChIP-Seq_LS180_Human | 1.62038509 |
| 43 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.61971206 |
| 44 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.61565955 |
| 45 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.58552318 |
| 46 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.52052415 |
| 47 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.50661672 |
| 48 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.49585392 |
| 49 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.45956038 |
| 50 | TP53_16413492_ChIP-PET_HCT116_Human | 1.45081994 |
| 51 | * BRD4_25478319_ChIP-Seq_HGPS_Human | 1.44674342 |
| 52 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.44378577 |
| 53 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.43876892 |
| 54 | TP63_23658742_ChIP-Seq_EP156T_Human | 1.43767515 |
| 55 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.40699054 |
| 56 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.40076218 |
| 57 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.39813958 |
| 58 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.39730440 |
| 59 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.38105855 |
| 60 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.36825933 |
| 61 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.36082284 |
| 62 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.34570861 |
| 63 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.34570861 |
| 64 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.32983029 |
| 65 | * JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.32647645 |
| 66 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.32143954 |
| 67 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.31487761 |
| 68 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.28044527 |
| 69 | * JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.27892940 |
| 70 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.27350292 |
| 71 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.26943846 |
| 72 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.26845731 |
| 73 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.26768846 |
| 74 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.26591083 |
| 75 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.25555740 |
| 76 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.24457059 |
| 77 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.21533681 |
| 78 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.21428944 |
| 79 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.20536969 |
| 80 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.20461723 |
| 81 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.20122355 |
| 82 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.19820365 |
| 83 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.19136273 |
| 84 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 1.18819858 |
| 85 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.18261419 |
| 86 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.18136863 |
| 87 | * SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.17867117 |
| 88 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.17838008 |
| 89 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.17221985 |
| 90 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.16624288 |
| 91 | * MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.15558324 |
| 92 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.15168489 |
| 93 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.12338143 |
| 94 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.11756096 |
| 95 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.09320427 |
| 96 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.08356137 |
| 97 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.07566770 |
| 98 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.06639735 |
| 99 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.06219427 |
| 100 | * SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.06121089 |
| 101 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.04559858 |
| 102 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.04171063 |
| 103 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.03805079 |
| 104 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.03638337 |
| 105 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.03579614 |
| 106 | * SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.03144408 |
| 107 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.01672613 |
| 108 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.01551844 |
| 109 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.01379769 |
| 110 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.00941816 |
| 111 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.00073497 |
| 112 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.99964788 |
| 113 | AR_25329375_ChIP-Seq_VCAP_Human | 0.99089841 |
| 114 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.96387007 |
| 115 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 0.95839529 |
| 116 | * TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.95222711 |
| 117 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.95154348 |
| 118 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.93256889 |
| 119 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.92751406 |
| 120 | * UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.91842797 |
| 121 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.91696822 |
| 122 | * FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.91310614 |
| 123 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.91149218 |
| 124 | * OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.91144058 |
| 125 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.90626242 |
| 126 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.90407933 |
| 127 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.90387333 |
| 128 | * SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.90082907 |
| 129 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 0.89251990 |
| 130 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 0.89163371 |
| 131 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 0.89156523 |
| 132 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 0.88663948 |
| 133 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.88612988 |
| 134 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.88451777 |
| 135 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.87828291 |
| 136 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.87717601 |
| 137 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.87637674 |
| 138 | P300_19829295_ChIP-Seq_ESCs_Human | 0.87389334 |
| 139 | * FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.86852359 |
| 140 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.86679424 |
| 141 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.86448748 |
| 142 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.85977178 |
| 143 | AR_19668381_ChIP-Seq_PC3_Human | 0.84880536 |
| 144 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.84798943 |
| 145 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 0.84410132 |
| 146 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.84346486 |
| 147 | * SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.84080382 |
| 148 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.83896044 |
| 149 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.83020172 |
| 150 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.82238259 |
| 151 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.82238259 |
| 152 | TCF4_23295773_ChIP-Seq_U87_Human | 0.81893764 |
| 153 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.80649096 |
| 154 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.80315545 |
| 155 | STAT3_23295773_ChIP-Seq_U87_Human | 0.80187277 |
| 156 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.79859483 |
| 157 | RNF2_27304074_Chip-Seq_NSC_Mouse | 0.79650140 |
| 158 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.79547527 |
| 159 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.79198298 |
| 160 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.78873817 |
| 161 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 0.78822529 |
| 162 | TBL1_22424771_ChIP-Seq_293T_Human | 0.78367050 |
| 163 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.77860503 |
| 164 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.77585026 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002837_dystrophic_cardiac_calcinosis | 4.94443495 |
| 2 | MP0003646_muscle_fatigue | 4.75123395 |
| 3 | MP0000751_myopathy | 4.40767413 |
| 4 | MP0004084_abnormal_cardiac_muscle | 3.62583108 |
| 5 | MP0004215_abnormal_myocardial_fiber | 3.48124205 |
| 6 | MP0004036_abnormal_muscle_relaxation | 3.27290610 |
| 7 | MP0000749_muscle_degeneration | 2.97668013 |
| 8 | MP0008438_abnormal_cutaneous_collagen | 2.81371379 |
| 9 | MP0005410_abnormal_fertilization | 2.80205080 |
| 10 | MP0004859_abnormal_synaptic_plasticity | 2.75873454 |
| 11 | MP0004145_abnormal_muscle_electrophysio | 2.48821299 |
| 12 | MP0005330_cardiomyopathy | 2.48812686 |
| 13 | MP0003880_abnormal_central_pattern | 2.35195082 |
| 14 | MP0002796_impaired_skin_barrier | 2.32222494 |
| 15 | MP0003191_abnormal_cellular_cholesterol | 2.29975432 |
| 16 | MP0002822_catalepsy | 2.20606267 |
| 17 | MP0004087_abnormal_muscle_fiber | 2.19654046 |
| 18 | MP0005620_abnormal_muscle_contractility | 2.17302666 |
| 19 | MP0003690_abnormal_glial_cell | 2.14165988 |
| 20 | MP0002972_abnormal_cardiac_muscle | 2.11539177 |
| 21 | MP0002877_abnormal_melanocyte_morpholog | 2.09526468 |
| 22 | MP0003137_abnormal_impulse_conducting | 2.08160518 |
| 23 | MP0004484_altered_response_of | 2.04860200 |
| 24 | MP0001958_emphysema | 1.93048083 |
| 25 | MP0002106_abnormal_muscle_physiology | 1.92196120 |
| 26 | MP0003635_abnormal_synaptic_transmissio | 1.85590969 |
| 27 | MP0004130_abnormal_muscle_cell | 1.85058194 |
| 28 | MP0006082_CNS_inflammation | 1.84554764 |
| 29 | MP0004270_analgesia | 1.83770580 |
| 30 | MP0004085_abnormal_heartbeat | 1.82680090 |
| 31 | MP0008775_abnormal_heart_ventricle | 1.79640551 |
| 32 | MP0000750_abnormal_muscle_regeneration | 1.75771715 |
| 33 | MP0003091_abnormal_cell_migration | 1.71418145 |
| 34 | MP0006138_congestive_heart_failure | 1.69677574 |
| 35 | MP0003279_aneurysm | 1.68347894 |
| 36 | MP0004233_abnormal_muscle_weight | 1.65011390 |
| 37 | MP0000747_muscle_weakness | 1.64908667 |
| 38 | MP0005164_abnormal_response_to | 1.64712464 |
| 39 | MP0005023_abnormal_wound_healing | 1.64425899 |
| 40 | MP0002269_muscular_atrophy | 1.62290029 |
| 41 | MP0003300_gastrointestinal_ulcer | 1.61986988 |
| 42 | MP0000465_gastrointestinal_hemorrhage | 1.61512697 |
| 43 | MP0003566_abnormal_cell_adhesion | 1.60685583 |
| 44 | MP0005369_muscle_phenotype | 1.60516920 |
| 45 | MP0005385_cardiovascular_system_phenoty | 1.59407857 |
| 46 | MP0001544_abnormal_cardiovascular_syste | 1.59407857 |
| 47 | MP0009745_abnormal_behavioral_response | 1.59304920 |
| 48 | MP0002234_abnormal_pharynx_morphology | 1.58069770 |
| 49 | MP0009046_muscle_twitch | 1.57270358 |
| 50 | MP0000759_abnormal_skeletal_muscle | 1.54711413 |
| 51 | MP0005275_abnormal_skin_tensile | 1.54550739 |
| 52 | MP0002998_abnormal_bone_remodeling | 1.54036867 |
| 53 | MP0000733_abnormal_muscle_development | 1.52900470 |
| 54 | MP0001984_abnormal_olfaction | 1.50711269 |
| 55 | MP0003045_fibrosis | 1.50674780 |
| 56 | MP0000003_abnormal_adipose_tissue | 1.50622360 |
| 57 | MP0002063_abnormal_learning/memory/cond | 1.47682003 |
| 58 | MP0003941_abnormal_skin_development | 1.47637703 |
| 59 | MP0001542_abnormal_bone_strength | 1.47329335 |
| 60 | MP0010234_abnormal_vibrissa_follicle | 1.47230315 |
| 61 | MP0009840_abnormal_foam_cell | 1.44204909 |
| 62 | MP0004272_abnormal_basement_membrane | 1.44120863 |
| 63 | MP0010630_abnormal_cardiac_muscle | 1.42926403 |
| 64 | MP0001348_abnormal_lacrimal_gland | 1.42749639 |
| 65 | MP0000569_abnormal_digit_pigmentation | 1.41904438 |
| 66 | MP0010386_abnormal_urinary_bladder | 1.40711661 |
| 67 | MP0003453_abnormal_keratinocyte_physiol | 1.38690413 |
| 68 | MP0002971_abnormal_brown_adipose | 1.38075039 |
| 69 | MP0002909_abnormal_adrenal_gland | 1.34122792 |
| 70 | MP0002064_seizures | 1.32715050 |
| 71 | MP0001968_abnormal_touch/_nociception | 1.31909917 |
| 72 | MP0002060_abnormal_skin_morphology | 1.28201150 |
| 73 | MP0002272_abnormal_nervous_system | 1.25869999 |
| 74 | MP0005058_abnormal_lysosome_morphology | 1.25827639 |
| 75 | MP0000579_abnormal_nail_morphology | 1.24905507 |
| 76 | MP0005623_abnormal_meninges_morphology | 1.23010333 |
| 77 | MP0001440_abnormal_grooming_behavior | 1.22109779 |
| 78 | MP0002572_abnormal_emotion/affect_behav | 1.21025913 |
| 79 | MP0003075_altered_response_to | 1.20142385 |
| 80 | MP0003705_abnormal_hypodermis_morpholog | 1.18402088 |
| 81 | MP0004858_abnormal_nervous_system | 1.18132292 |
| 82 | MP0000604_amyloidosis | 1.17470355 |
| 83 | MP0005503_abnormal_tendon_morphology | 1.14786498 |
| 84 | MP0000920_abnormal_myelination | 1.14028014 |
| 85 | MP0004947_skin_inflammation | 1.13987644 |
| 86 | MP0002332_abnormal_exercise_endurance | 1.13853204 |
| 87 | MP0002896_abnormal_bone_mineralization | 1.13126991 |
| 88 | MP0010368_abnormal_lymphatic_system | 1.11258512 |
| 89 | MP0000681_abnormal_thyroid_gland | 1.10684900 |
| 90 | MP0005166_decreased_susceptibility_to | 1.09908012 |
| 91 | MP0003828_pulmonary_edema | 1.07769792 |
| 92 | MP0001486_abnormal_startle_reflex | 1.07540631 |
| 93 | MP0002876_abnormal_thyroid_physiology | 1.07230172 |
| 94 | MP0002736_abnormal_nociception_after | 1.06326718 |
| 95 | MP0004883_abnormal_blood_vessel | 1.05945524 |
| 96 | MP0008569_lethality_at_weaning | 1.05714597 |
| 97 | MP0003950_abnormal_plasma_membrane | 1.04521481 |
| 98 | MP0002735_abnormal_chemical_nociception | 1.04274925 |
| 99 | MP0001661_extended_life_span | 1.03746376 |
| 100 | MP0004510_myositis | 1.02693792 |
| 101 | MP0002734_abnormal_mechanical_nocicepti | 1.01850204 |
| 102 | MP0005501_abnormal_skin_physiology | 1.00402902 |
| 103 | MP0000383_abnormal_hair_follicle | 1.00338091 |
| 104 | MP0003329_amyloid_beta_deposits | 1.00152092 |
| 105 | MP0000343_altered_response_to | 0.99578683 |
| 106 | MP0000685_abnormal_immune_system | 0.98285530 |
| 107 | MP0001851_eye_inflammation | 0.97744510 |
| 108 | MP0009780_abnormal_chondrocyte_physiolo | 0.97374358 |
| 109 | MP0000013_abnormal_adipose_tissue | 0.95972177 |
| 110 | MP0001501_abnormal_sleep_pattern | 0.93424870 |
| 111 | MP0008961_abnormal_basal_metabolism | 0.92834822 |
| 112 | MP0010352_gastrointestinal_tract_polyps | 0.90723534 |
| 113 | MP0005666_abnormal_adipose_tissue | 0.90559591 |
| 114 | MP0002067_abnormal_sensory_capabilities | 0.89801378 |
| 115 | MP0003724_increased_susceptibility_to | 0.89291710 |
| 116 | MP0003698_abnormal_male_reproductive | 0.88830952 |
| 117 | MP0001533_abnormal_skeleton_physiology | 0.87928937 |
| 118 | MP0003172_abnormal_lysosome_physiology | 0.86950453 |
| 119 | MP0005386_behavior/neurological_phenoty | 0.86899896 |
| 120 | MP0004924_abnormal_behavior | 0.86899896 |
| 121 | MP0002419_abnormal_innate_immunity | 0.86572731 |
| 122 | MP0002108_abnormal_muscle_morphology | 0.85877782 |
| 123 | MP0005670_abnormal_white_adipose | 0.85297953 |
| 124 | MP0004185_abnormal_adipocyte_glucose | 0.85284829 |
| 125 | MP0003448_altered_tumor_morphology | 0.84099109 |
| 126 | MP0006036_abnormal_mitochondrial_physio | 0.83553736 |
| 127 | MP0005595_abnormal_vascular_smooth | 0.83321066 |
| 128 | MP0002184_abnormal_innervation | 0.83225897 |
| 129 | MP0002127_abnormal_cardiovascular_syste | 0.82429010 |
| 130 | MP0001970_abnormal_pain_threshold | 0.82280941 |
| 131 | MP0005409_darkened_coat_color | 0.82249152 |
| 132 | MP0005423_abnormal_somatic_nervous | 0.81103703 |
| 133 | MP0002166_altered_tumor_susceptibility | 0.79974844 |
| 134 | MP0001216_abnormal_epidermal_layer | 0.78234798 |
| 135 | MP0001529_abnormal_vocalization | 0.76511655 |
| 136 | MP0002733_abnormal_thermal_nociception | 0.76276252 |
| 137 | MP0003436_decreased_susceptibility_to | 0.75359018 |
| 138 | MP0005165_increased_susceptibility_to | 0.74829228 |
| 139 | MP0010771_integument_phenotype | 0.74081728 |
| 140 | MP0005187_abnormal_penis_morphology | 0.74076019 |
| 141 | MP0006276_abnormal_autonomic_nervous | 0.72913965 |
| 142 | MP0002557_abnormal_social/conspecific_i | 0.71707618 |
| 143 | MP0005375_adipose_tissue_phenotype | 0.71158975 |
| 144 | MP0003795_abnormal_bone_structure | 0.70964584 |
| 145 | MP0003221_abnormal_cardiomyocyte_apopto | 0.70332129 |
| 146 | MP0005379_endocrine/exocrine_gland_phen | 0.69974466 |
| 147 | MP0006035_abnormal_mitochondrial_morpho | 0.65802266 |
| 148 | MP0003879_abnormal_hair_cell | 0.64960945 |
| 149 | MP0005451_abnormal_body_composition | 0.62903817 |
| 150 | MP0010678_abnormal_skin_adnexa | 0.62864515 |
| 151 | MP0002066_abnormal_motor_capabilities/c | 0.61979040 |
| 152 | MP0000230_abnormal_systemic_arterial | 0.61607870 |
| 153 | MP0004811_abnormal_neuron_physiology | 0.60785374 |
| 154 | MP0002882_abnormal_neuron_morphology | 0.60449902 |
| 155 | MP0001765_abnormal_ion_homeostasis | 0.58804356 |
| 156 | MP0004043_abnormal_pH_regulation | 0.58738840 |
| 157 | MP0002254_reproductive_system_inflammat | 0.58513157 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Sudden death (HP:0001699) | 6.27702539 |
| 2 | Exercise-induced myalgia (HP:0003738) | 5.78516485 |
| 3 | Calf muscle hypertrophy (HP:0008981) | 5.43199735 |
| 4 | Muscle hypertrophy of the lower extremities (HP:0008968) | 5.17962035 |
| 5 | Ventricular tachycardia (HP:0004756) | 5.00564218 |
| 6 | Hyporeflexia of lower limbs (HP:0002600) | 4.89852699 |
| 7 | Exercise-induced muscle cramps (HP:0003710) | 4.76494591 |
| 8 | Right ventricular cardiomyopathy (HP:0011663) | 4.67856976 |
| 9 | Abnormality of the calf musculature (HP:0001430) | 4.45811806 |
| 10 | Atrial fibrillation (HP:0005110) | 4.45389729 |
| 11 | Ventricular fibrillation (HP:0001663) | 4.27523849 |
| 12 | Primary atrial arrhythmia (HP:0001692) | 4.23778903 |
| 13 | Muscle fiber splitting (HP:0003555) | 4.22256408 |
| 14 | Syncope (HP:0001279) | 4.10492362 |
| 15 | Supraventricular tachycardia (HP:0004755) | 4.02617610 |
| 16 | Absent/shortened dynein arms (HP:0200106) | 3.99389020 |
| 17 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 3.99389020 |
| 18 | Bundle branch block (HP:0011710) | 3.95150697 |
| 19 | Supraventricular arrhythmia (HP:0005115) | 3.92441226 |
| 20 | Myoglobinuria (HP:0002913) | 3.75589288 |
| 21 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 3.66900925 |
| 22 | Difficulty running (HP:0009046) | 3.62547279 |
| 23 | Prolonged QT interval (HP:0001657) | 3.54023414 |
| 24 | EMG: myopathic abnormalities (HP:0003458) | 3.33346763 |
| 25 | Abnormality of glycolipid metabolism (HP:0010969) | 3.33057454 |
| 26 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.33057454 |
| 27 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.33057454 |
| 28 | Ventricular arrhythmia (HP:0004308) | 3.29370128 |
| 29 | Abnormality of the left ventricular outflow tract (HP:0011103) | 3.16608585 |
| 30 | Subaortic stenosis (HP:0001682) | 3.16608585 |
| 31 | Lipoatrophy (HP:0100578) | 3.15947522 |
| 32 | Alopecia of scalp (HP:0002293) | 3.09691558 |
| 33 | Heart block (HP:0012722) | 3.09630388 |
| 34 | Myotonia (HP:0002486) | 3.04792169 |
| 35 | Focal motor seizures (HP:0011153) | 3.03301393 |
| 36 | Atrophic scars (HP:0001075) | 3.01840696 |
| 37 | Palpitations (HP:0001962) | 3.01708147 |
| 38 | Abnormal atrioventricular conduction (HP:0005150) | 3.00245868 |
| 39 | Increased connective tissue (HP:0009025) | 3.00005410 |
| 40 | Abnormal respiratory motile cilium physiology (HP:0012261) | 2.98456132 |
| 41 | Thoracolumbar scoliosis (HP:0002944) | 2.97484655 |
| 42 | Arterial tortuosity (HP:0005116) | 2.94229247 |
| 43 | Neurofibrillary tangles (HP:0002185) | 2.92552582 |
| 44 | Muscle fiber inclusion bodies (HP:0100299) | 2.91124480 |
| 45 | Vascular tortuosity (HP:0004948) | 2.91013004 |
| 46 | Asymmetric septal hypertrophy (HP:0001670) | 2.89060910 |
| 47 | Spondylolisthesis (HP:0003302) | 2.88507577 |
| 48 | Abnormal EKG (HP:0003115) | 2.78729784 |
| 49 | Atrioventricular block (HP:0001678) | 2.78514302 |
| 50 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.76637830 |
| 51 | Dilated cardiomyopathy (HP:0001644) | 2.73189272 |
| 52 | Difficulty climbing stairs (HP:0003551) | 2.68238136 |
| 53 | Increased variability in muscle fiber diameter (HP:0003557) | 2.67659747 |
| 54 | Osteolytic defects of the hand bones (HP:0009699) | 2.64876875 |
| 55 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.64876875 |
| 56 | Type 1 muscle fiber predominance (HP:0003803) | 2.63507577 |
| 57 | Aortic aneurysm (HP:0004942) | 2.63243618 |
| 58 | Increased CSF protein (HP:0002922) | 2.62352233 |
| 59 | Abnormal respiratory epithelium morphology (HP:0012253) | 2.60791537 |
| 60 | Abnormal respiratory motile cilium morphology (HP:0005938) | 2.60791537 |
| 61 | Myokymia (HP:0002411) | 2.58936555 |
| 62 | Tetraparesis (HP:0002273) | 2.57406903 |
| 63 | Protrusio acetabuli (HP:0003179) | 2.54929192 |
| 64 | Abnormal ciliary motility (HP:0012262) | 2.54359462 |
| 65 | Distal lower limb muscle weakness (HP:0009053) | 2.48161862 |
| 66 | Areflexia of lower limbs (HP:0002522) | 2.45407161 |
| 67 | Aortic dissection (HP:0002647) | 2.45224078 |
| 68 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.39888467 |
| 69 | Palmoplantar keratoderma (HP:0000982) | 2.39807161 |
| 70 | Left ventricular hypertrophy (HP:0001712) | 2.39613464 |
| 71 | Muscle stiffness (HP:0003552) | 2.39588302 |
| 72 | Dysmetric saccades (HP:0000641) | 2.38565401 |
| 73 | Onycholysis (HP:0001806) | 2.35978694 |
| 74 | Vertebral compression fractures (HP:0002953) | 2.35823608 |
| 75 | Striae distensae (HP:0001065) | 2.35415576 |
| 76 | Rhabdomyolysis (HP:0003201) | 2.34033897 |
| 77 | Congenital malformation of the right heart (HP:0011723) | 2.32804218 |
| 78 | Double outlet right ventricle (HP:0001719) | 2.32804218 |
| 79 | Milia (HP:0001056) | 2.32591097 |
| 80 | Conjunctival hamartoma (HP:0100780) | 2.32314984 |
| 81 | Nemaline bodies (HP:0003798) | 2.29059415 |
| 82 | Cerebral inclusion bodies (HP:0100314) | 2.28300476 |
| 83 | Mitral stenosis (HP:0001718) | 2.25797189 |
| 84 | Distal lower limb amyotrophy (HP:0008944) | 2.23035009 |
| 85 | Rhinitis (HP:0012384) | 2.19821212 |
| 86 | Abnormality of macular pigmentation (HP:0008002) | 2.16780543 |
| 87 | Thick nail (HP:0001805) | 2.15825475 |
| 88 | EMG: neuropathic changes (HP:0003445) | 2.15567403 |
| 89 | Lower limb amyotrophy (HP:0007210) | 2.12380565 |
| 90 | Acute necrotizing encephalopathy (HP:0006965) | 2.11196867 |
| 91 | Wormian bones (HP:0002645) | 2.10088306 |
| 92 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.09292401 |
| 93 | Fatigue (HP:0012378) | 2.09275227 |
| 94 | Neck muscle weakness (HP:0000467) | 2.08895154 |
| 95 | Premature rupture of membranes (HP:0001788) | 2.05240070 |
| 96 | Testicular atrophy (HP:0000029) | 2.05096013 |
| 97 | Ulnar deviation of the wrist (HP:0003049) | 2.03910315 |
| 98 | Central scotoma (HP:0000603) | 2.03520755 |
| 99 | Spinal cord lesions (HP:0100561) | 2.03204093 |
| 100 | Syringomyelia (HP:0003396) | 2.03204093 |
| 101 | Chronic bronchitis (HP:0004469) | 2.03125766 |
| 102 | Foot dorsiflexor weakness (HP:0009027) | 2.01815592 |
| 103 | Abnormality of the foot musculature (HP:0001436) | 2.01266697 |
| 104 | Focal seizures (HP:0007359) | 1.99981877 |
| 105 | Hypotrichosis (HP:0001006) | 1.97153519 |
| 106 | Rapidly progressive (HP:0003678) | 1.96992683 |
| 107 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.96788415 |
| 108 | Glucose intolerance (HP:0000833) | 1.96609223 |
| 109 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.96163797 |
| 110 | Frequent falls (HP:0002359) | 1.93481020 |
| 111 | Absent frontal sinuses (HP:0002688) | 1.91899458 |
| 112 | Round ear (HP:0100830) | 1.91666479 |
| 113 | Hamartoma of the eye (HP:0010568) | 1.91211897 |
| 114 | Limb-girdle muscle atrophy (HP:0003797) | 1.90895138 |
| 115 | Eczematoid dermatitis (HP:0000976) | 1.90797416 |
| 116 | Progressive macrocephaly (HP:0004481) | 1.90556615 |
| 117 | Interstitial pulmonary disease (HP:0006530) | 1.90031667 |
| 118 | Peritonitis (HP:0002586) | 1.88990656 |
| 119 | Abnormality of the columella (HP:0009929) | 1.86682743 |
| 120 | Spinal rigidity (HP:0003306) | 1.86503095 |
| 121 | Palmoplantar hyperkeratosis (HP:0000972) | 1.86464894 |
| 122 | Infertility (HP:0000789) | 1.85515011 |
| 123 | Pheochromocytoma (HP:0002666) | 1.85204233 |
| 124 | Supranuclear gaze palsy (HP:0000605) | 1.85079635 |
| 125 | Visual hallucinations (HP:0002367) | 1.84494456 |
| 126 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.84080314 |
| 127 | Dysostosis multiplex (HP:0000943) | 1.83752879 |
| 128 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.83256971 |
| 129 | Mucopolysacchariduria (HP:0008155) | 1.83256971 |
| 130 | Dysdiadochokinesis (HP:0002075) | 1.80420101 |
| 131 | Abnormality of the neuromuscular junction (HP:0003398) | 1.79711415 |
| 132 | Fatigable weakness (HP:0003473) | 1.79711415 |
| 133 | Cone-rod dystrophy (HP:0000548) | 1.79057349 |
| 134 | Distal arthrogryposis (HP:0005684) | 1.78685854 |
| 135 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.77775179 |
| 136 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.77775179 |
| 137 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.77775179 |
| 138 | Rimmed vacuoles (HP:0003805) | 1.76822609 |
| 139 | Gowers sign (HP:0003391) | 1.76307718 |
| 140 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 1.75956965 |
| 141 | Craniofacial hyperostosis (HP:0004493) | 1.74450622 |
| 142 | Papillary thyroid carcinoma (HP:0002895) | 1.74439572 |
| 143 | Hypoplasia of dental enamel (HP:0006297) | 1.73592754 |
| 144 | Hyperkalemia (HP:0002153) | 1.72409436 |
| 145 | Metaphyseal dysplasia (HP:0100255) | 1.72266491 |
| 146 | Cubitus valgus (HP:0002967) | 1.71761234 |
| 147 | Nuclear cataract (HP:0100018) | 1.71576446 |
| 148 | Fragile skin (HP:0001030) | 1.71496850 |
| 149 | Muscular dystrophy (HP:0003560) | 1.71306360 |
| 150 | Sudden cardiac death (HP:0001645) | 1.69448220 |
| 151 | Palmar hyperkeratosis (HP:0010765) | 1.69076804 |
| 152 | Bradycardia (HP:0001662) | 1.68751335 |
| 153 | Progressive cerebellar ataxia (HP:0002073) | 1.67876480 |
| 154 | Plantar hyperkeratosis (HP:0007556) | 1.67779768 |
| 155 | Abnormality of the vocal cords (HP:0008777) | 1.67676620 |
| 156 | Myocardial infarction (HP:0001658) | 1.67304495 |
| 157 | Proximal amyotrophy (HP:0007126) | 1.67300845 |
| 158 | Steppage gait (HP:0003376) | 1.66941950 |
| 159 | Cranial hyperostosis (HP:0004437) | 1.66049271 |
| 160 | Atonic seizures (HP:0010819) | 1.66039798 |
| 161 | Loss of speech (HP:0002371) | 1.65632777 |
| 162 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 1.64944614 |
| 163 | Bulbar palsy (HP:0001283) | 1.64898085 |
| 164 | Menstrual irregularities (HP:0000858) | 1.63915712 |
| 165 | Dilatation of the ascending aorta (HP:0005111) | 1.63599804 |
| 166 | Acanthosis nigricans (HP:0000956) | 1.60278342 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PDK4 | 4.25726253 |
| 2 | PDK3 | 4.25726253 |
| 3 | PHKG1 | 3.35668782 |
| 4 | PHKG2 | 3.35668782 |
| 5 | TTN | 3.28210426 |
| 6 | EPHA4 | 3.17501404 |
| 7 | OBSCN | 3.10796795 |
| 8 | LMTK2 | 2.86566723 |
| 9 | PRKD3 | 2.85982408 |
| 10 | PDK2 | 2.53172523 |
| 11 | TGFBR2 | 2.32470773 |
| 12 | MUSK | 2.15121757 |
| 13 | PINK1 | 2.04815945 |
| 14 | NTRK3 | 1.99183826 |
| 15 | DMPK | 1.93422566 |
| 16 | MAP3K13 | 1.83903825 |
| 17 | EPHB1 | 1.76755287 |
| 18 | STK38 | 1.72304705 |
| 19 | MET | 1.65062422 |
| 20 | NEK9 | 1.62933989 |
| 21 | MAP3K9 | 1.61930970 |
| 22 | MOS | 1.61193577 |
| 23 | FRK | 1.48862457 |
| 24 | BMPR2 | 1.48314232 |
| 25 | MAP3K3 | 1.47329433 |
| 26 | MYLK | 1.46944254 |
| 27 | PIK3CG | 1.40622858 |
| 28 | MAP3K4 | 1.38459238 |
| 29 | TAOK3 | 1.36282785 |
| 30 | GRK7 | 1.33549425 |
| 31 | PTK2B | 1.32987937 |
| 32 | JAK1 | 1.32211926 |
| 33 | WNK4 | 1.30368593 |
| 34 | PDGFRA | 1.30115618 |
| 35 | MAPK7 | 1.28595434 |
| 36 | NTRK2 | 1.27397975 |
| 37 | MAPKAPK3 | 1.23284075 |
| 38 | KSR2 | 1.23179766 |
| 39 | TRIB3 | 1.22881202 |
| 40 | MAP3K6 | 1.22401441 |
| 41 | FER | 1.22009965 |
| 42 | MAP2K4 | 1.20396927 |
| 43 | ICK | 1.18824077 |
| 44 | MAP3K14 | 1.15511932 |
| 45 | STK24 | 1.15227844 |
| 46 | ZAP70 | 1.13546288 |
| 47 | PAK3 | 1.13450536 |
| 48 | ERN1 | 1.13130309 |
| 49 | AKT3 | 1.11004223 |
| 50 | TESK1 | 1.10914790 |
| 51 | PTK2 | 1.10839647 |
| 52 | DDR2 | 1.08695362 |
| 53 | MINK1 | 1.08470876 |
| 54 | PRPF4B | 1.07848464 |
| 55 | MAP2K3 | 1.07439029 |
| 56 | NME1 | 1.05959368 |
| 57 | GRK5 | 1.02434738 |
| 58 | CAMK2A | 1.02083979 |
| 59 | RIPK4 | 1.01162758 |
| 60 | NEK1 | 1.00098921 |
| 61 | CAMK2D | 0.99913555 |
| 62 | PAK6 | 0.98720265 |
| 63 | LATS2 | 0.97199497 |
| 64 | DAPK2 | 0.96747833 |
| 65 | MAP3K7 | 0.94137499 |
| 66 | STK39 | 0.93323771 |
| 67 | PDGFRB | 0.92875027 |
| 68 | CAMKK1 | 0.91241168 |
| 69 | IRAK3 | 0.90536080 |
| 70 | TAOK1 | 0.90202586 |
| 71 | PNCK | 0.89366618 |
| 72 | TBK1 | 0.88217697 |
| 73 | WNK1 | 0.87205793 |
| 74 | LIMK1 | 0.85533093 |
| 75 | NLK | 0.85412511 |
| 76 | MAP3K2 | 0.84455233 |
| 77 | PRKD1 | 0.84252512 |
| 78 | HIPK2 | 0.82961009 |
| 79 | MARK1 | 0.82539290 |
| 80 | RPS6KA2 | 0.81028471 |
| 81 | PKN2 | 0.76796039 |
| 82 | ROCK1 | 0.76512200 |
| 83 | PIK3CA | 0.76221156 |
| 84 | EPHB2 | 0.75222807 |
| 85 | CDK5 | 0.74282784 |
| 86 | KIT | 0.73679625 |
| 87 | EPHA3 | 0.73008956 |
| 88 | JAK3 | 0.72536788 |
| 89 | EPHA2 | 0.71507089 |
| 90 | DAPK3 | 0.70880601 |
| 91 | NTRK1 | 0.70204173 |
| 92 | MAP2K7 | 0.69934417 |
| 93 | TYRO3 | 0.69719664 |
| 94 | CAMK1 | 0.69070585 |
| 95 | CASK | 0.68315303 |
| 96 | PRKG2 | 0.68039153 |
| 97 | MAPK12 | 0.67634914 |
| 98 | FGFR3 | 0.67624588 |
| 99 | IRAK4 | 0.65823989 |
| 100 | TYK2 | 0.65729689 |
| 101 | ABL2 | 0.64692426 |
| 102 | MAP3K1 | 0.63963087 |
| 103 | PDK1 | 0.63645016 |
| 104 | STK11 | 0.62894725 |
| 105 | PDPK1 | 0.62815048 |
| 106 | DAPK1 | 0.62786511 |
| 107 | FLT3 | 0.62334311 |
| 108 | ERBB3 | 0.62174354 |
| 109 | TRPM7 | 0.60318405 |
| 110 | PRKCE | 0.60102017 |
| 111 | CAMKK2 | 0.59201288 |
| 112 | CDC42BPA | 0.58508889 |
| 113 | TIE1 | 0.57516597 |
| 114 | STK38L | 0.57269265 |
| 115 | RET | 0.56689340 |
| 116 | CSK | 0.56567960 |
| 117 | ERBB4 | 0.56346061 |
| 118 | ROCK2 | 0.54359060 |
| 119 | JAK2 | 0.53790478 |
| 120 | PRKACA | 0.52361596 |
| 121 | BCR | 0.52244964 |
| 122 | MAPK10 | 0.50902497 |
| 123 | CAMK2G | 0.50805828 |
| 124 | SGK1 | 0.50461013 |
| 125 | PKN1 | 0.50376109 |
| 126 | RPS6KL1 | 0.50195821 |
| 127 | RPS6KC1 | 0.50195821 |
| 128 | PRKCG | 0.49367257 |
| 129 | KSR1 | 0.48577928 |
| 130 | PRKAA1 | 0.48401995 |
| 131 | TNIK | 0.47901761 |
| 132 | IRAK2 | 0.46856807 |
| 133 | RIPK1 | 0.46163462 |
| 134 | CAMK4 | 0.46130589 |
| 135 | MARK3 | 0.45013601 |
| 136 | TXK | 0.43816172 |
| 137 | MAP2K6 | 0.42819742 |
| 138 | STK3 | 0.42721094 |
| 139 | MAP3K5 | 0.41963353 |
| 140 | MARK2 | 0.41549390 |
| 141 | MAP2K1 | 0.41410391 |
| 142 | SGK2 | 0.41404580 |
| 143 | MST1R | 0.41121434 |
| 144 | CAMK2B | 0.40340381 |
| 145 | ILK | 0.40281064 |
| 146 | ARAF | 0.38979185 |
| 147 | MAP3K12 | 0.38301058 |
| 148 | CAMK1G | 0.38211232 |
| 149 | SGK223 | 0.38132303 |
| 150 | SGK494 | 0.38132303 |
| 151 | PRKACG | 0.37677295 |
| 152 | LATS1 | 0.37631442 |
| 153 | PLK2 | 0.36542624 |
| 154 | SGK3 | 0.36318597 |
| 155 | PRKAA2 | 0.36315987 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 3.28579138 |
| 2 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.91169210 |
| 3 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 2.43751703 |
| 4 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 2.21155030 |
| 5 | Olfactory transduction_Homo sapiens_hsa04740 | 2.15060871 |
| 6 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.12933092 |
| 7 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 2.06844456 |
| 8 | Parkinsons disease_Homo sapiens_hsa05012 | 2.00297322 |
| 9 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.89119144 |
| 10 | Nicotine addiction_Homo sapiens_hsa05033 | 1.86948269 |
| 11 | Circadian entrainment_Homo sapiens_hsa04713 | 1.85821605 |
| 12 | Alzheimers disease_Homo sapiens_hsa05010 | 1.81483560 |
| 13 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.76040295 |
| 14 | Long-term potentiation_Homo sapiens_hsa04720 | 1.75051325 |
| 15 | Renin secretion_Homo sapiens_hsa04924 | 1.74148297 |
| 16 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.71196289 |
| 17 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.70193026 |
| 18 | Salivary secretion_Homo sapiens_hsa04970 | 1.62345148 |
| 19 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.60939705 |
| 20 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.58893992 |
| 21 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.57813958 |
| 22 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.54937798 |
| 23 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.53834626 |
| 24 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.53296972 |
| 25 | Focal adhesion_Homo sapiens_hsa04510 | 1.52031513 |
| 26 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.51299260 |
| 27 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.50834278 |
| 28 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.50321502 |
| 29 | Lysosome_Homo sapiens_hsa04142 | 1.48956991 |
| 30 | Insulin secretion_Homo sapiens_hsa04911 | 1.47512232 |
| 31 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.44952643 |
| 32 | Taste transduction_Homo sapiens_hsa04742 | 1.44097214 |
| 33 | GABAergic synapse_Homo sapiens_hsa04727 | 1.43948480 |
| 34 | Huntingtons disease_Homo sapiens_hsa05016 | 1.43089191 |
| 35 | Morphine addiction_Homo sapiens_hsa05032 | 1.40306417 |
| 36 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.35917814 |
| 37 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.35497101 |
| 38 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.33941160 |
| 39 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 1.33687192 |
| 40 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.27796380 |
| 41 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.25067605 |
| 42 | Other glycan degradation_Homo sapiens_hsa00511 | 1.23232519 |
| 43 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.20777292 |
| 44 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.20636303 |
| 45 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.16718333 |
| 46 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.16713833 |
| 47 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.13566796 |
| 48 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.12532049 |
| 49 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.12256549 |
| 50 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.08900426 |
| 51 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.08457621 |
| 52 | Amoebiasis_Homo sapiens_hsa05146 | 1.07701828 |
| 53 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.05916532 |
| 54 | Cocaine addiction_Homo sapiens_hsa05030 | 1.05839660 |
| 55 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.05132458 |
| 56 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.04161668 |
| 57 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.03506051 |
| 58 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.03165862 |
| 59 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.03087495 |
| 60 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.01990022 |
| 61 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.00478886 |
| 62 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.00012188 |
| 63 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.99512746 |
| 64 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.97669304 |
| 65 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.94489679 |
| 66 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.93085530 |
| 67 | Malaria_Homo sapiens_hsa05144 | 0.92372619 |
| 68 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.91859335 |
| 69 | Carbon metabolism_Homo sapiens_hsa01200 | 0.91734968 |
| 70 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.91512131 |
| 71 | Melanogenesis_Homo sapiens_hsa04916 | 0.89064723 |
| 72 | Phototransduction_Homo sapiens_hsa04744 | 0.88839440 |
| 73 | Platelet activation_Homo sapiens_hsa04611 | 0.87244915 |
| 74 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.86819053 |
| 75 | Gap junction_Homo sapiens_hsa04540 | 0.86338461 |
| 76 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.85924438 |
| 77 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.85343035 |
| 78 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.85183301 |
| 79 | Long-term depression_Homo sapiens_hsa04730 | 0.84453813 |
| 80 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.83735167 |
| 81 | Adherens junction_Homo sapiens_hsa04520 | 0.83707112 |
| 82 | Phagosome_Homo sapiens_hsa04145 | 0.83644495 |
| 83 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.82400574 |
| 84 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.80998968 |
| 85 | Endocytosis_Homo sapiens_hsa04144 | 0.80981248 |
| 86 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.79782214 |
| 87 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.78862662 |
| 88 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.78697559 |
| 89 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.78251082 |
| 90 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.77959898 |
| 91 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.77693212 |
| 92 | Axon guidance_Homo sapiens_hsa04360 | 0.77273557 |
| 93 | Tuberculosis_Homo sapiens_hsa05152 | 0.76586034 |
| 94 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.75224043 |
| 95 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.75195158 |
| 96 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.74795847 |
| 97 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.74283914 |
| 98 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.74268778 |
| 99 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.72788790 |
| 100 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.72742042 |
| 101 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.72293573 |
| 102 | Salmonella infection_Homo sapiens_hsa05132 | 0.70691337 |
| 103 | Pertussis_Homo sapiens_hsa05133 | 0.70505086 |
| 104 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.70348836 |
| 105 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.70086013 |
| 106 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.69875984 |
| 107 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.69546528 |
| 108 | Tight junction_Homo sapiens_hsa04530 | 0.69371429 |
| 109 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.69312410 |
| 110 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.68933087 |
| 111 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.68362203 |
| 112 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.67549499 |
| 113 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.66927133 |
| 114 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.65768157 |
| 115 | Measles_Homo sapiens_hsa05162 | 0.64800469 |
| 116 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.64126088 |
| 117 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.62284759 |
| 118 | Circadian rhythm_Homo sapiens_hsa04710 | 0.61803852 |
| 119 | Leishmaniasis_Homo sapiens_hsa05140 | 0.61426431 |
| 120 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.61166957 |
| 121 | Thyroid cancer_Homo sapiens_hsa05216 | 0.60615875 |
| 122 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.60454062 |
| 123 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.58346892 |
| 124 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.57637124 |
| 125 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.57455222 |
| 126 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.55176127 |
| 127 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.54963931 |
| 128 | Insulin resistance_Homo sapiens_hsa04931 | 0.54870419 |
| 129 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.54865454 |
| 130 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.53900250 |
| 131 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.53273259 |
| 132 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.50703919 |
| 133 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.49582409 |
| 134 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.48870612 |
| 135 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.48637941 |
| 136 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.48128974 |
| 137 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.46787289 |
| 138 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.46418336 |
| 139 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.45888391 |
| 140 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.44800422 |
| 141 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.44721801 |
| 142 | Glioma_Homo sapiens_hsa05214 | 0.43249995 |
| 143 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.43027234 |
| 144 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.42598809 |
| 145 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.41757622 |
| 146 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.41183815 |
| 147 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.40504997 |
| 148 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.39720650 |
| 149 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.39411978 |
| 150 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.39356796 |
| 151 | Viral myocarditis_Homo sapiens_hsa05416 | 0.37679511 |
| 152 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.37076915 |
| 153 | Mineral absorption_Homo sapiens_hsa04978 | 0.36773509 |
| 154 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.35428057 |
| 155 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.34209217 |

